Merck, Moderna claim 'promising' skin cancer vaccine results in key trial
IOL
—
The vaccine, called intismeran autogene, showed "statistically significant and clinically meaningful improvements" for skin cancer patients when used with Merck's Keytruda treatment
Merck, Moderna melanoma vaccine succeeds
- Merck, Moderna Melanoma Vaccine Study Succeeds Bloomberg —
- Merck, Moderna claim encouraging melanoma vaccine trial results South China Morning Post —
- Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning The New York Times —
- Merck, Moderna Stocks Soar After Melanoma Trial Success 📹 Bloomberg — · 2min
- Moderna Cancer Trial Success Is a Shot in the Arm for Trump Newsweek —